Arkuda Therapeutics
Leveraging new insights into progranulin and lysosomal biology to discover therapies to change the trajectory of neurodegenerative disease.
$64M Series B+ ·
Led by Cormorant Asset Management · Source: fundraisingfox.com
Total raised: $108M across 2 sourced rounds
All 2 rounds ↓Signals
Arkuda Therapeutics | 625 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $64M | fundraisingfox.com | ||
| Series A | $44M | prnewswire.com |
Timeline
- X account created
- Website created
Founders and team
DB
Duane Burnett FounderGK
Gerhard Koenig Founder
Investors
AAtlas Venturelead investor
CCormorant Asset Managementlead investor
EEli Lilly
MMichael J. Fox Foundation
MMission BioCapital
PPfizer Venture Investmentslead investor
PPivotal bioVenture Partnerslead investor
SSurveyor Capital
TTekla Capital Management
Companies like Arkuda Therapeutics
SSentinal4DPre Seed · Dec 2024AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
AAlzheon$100M Series B+ · Apr 2022
SSironaxSeries B+ · Sep 2025
MMirador Therapeutics$250M Series B+ · Jan 2026
BBiocartesian$500K
Other companies backed by Cormorant Asset Management
DDren Bio$350M Series B+ · Oct 2026SStar Therapeutics$200M Series B+ · Oct 2026
EEpicrispr Biotechnologies$90M Series B+ · Aug 2026
FFore Biotherapeutics$67.4M Series B+ · Jul 2026
TThird Arc Bio$52M Series A · Feb 2026
AAspen Neuroscience$115M Series B+ · Nov 2025
Cormorant Asset Management portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arkuda-therapeutics (get a free API key).